MX2022007304A - Uso de lemborexant para tratamiento del insomnio. - Google Patents
Uso de lemborexant para tratamiento del insomnio.Info
- Publication number
- MX2022007304A MX2022007304A MX2022007304A MX2022007304A MX2022007304A MX 2022007304 A MX2022007304 A MX 2022007304A MX 2022007304 A MX2022007304 A MX 2022007304A MX 2022007304 A MX2022007304 A MX 2022007304A MX 2022007304 A MX2022007304 A MX 2022007304A
- Authority
- MX
- Mexico
- Prior art keywords
- lemborexant
- pharmaceutically acceptable
- acceptable salt
- treating insomnia
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962951638P | 2019-12-20 | 2019-12-20 | |
| PCT/US2020/065891 WO2021127359A1 (en) | 2019-12-20 | 2020-12-18 | Use of lemborexant for treating insomnia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022007304A true MX2022007304A (es) | 2022-08-22 |
Family
ID=74191874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022007304A MX2022007304A (es) | 2019-12-20 | 2020-12-18 | Uso de lemborexant para tratamiento del insomnio. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230051268A1 (https=) |
| EP (1) | EP4076463A1 (https=) |
| JP (2) | JP2023508011A (https=) |
| KR (1) | KR20220119065A (https=) |
| CN (1) | CN115003305A (https=) |
| AU (1) | AU2020408557A1 (https=) |
| BR (1) | BR112022012246A2 (https=) |
| CA (1) | CA3165481A1 (https=) |
| MX (1) | MX2022007304A (https=) |
| TW (1) | TW202137986A (https=) |
| WO (1) | WO2021127359A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024305901A1 (en) * | 2023-06-29 | 2026-02-12 | Janssen Pharmaceutica Nv | Method of treating depression using seltorexant |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0828751A4 (en) | 1995-05-05 | 1999-01-20 | Human Genome Sciences Inc | HUMAN NEUROPEPTIDE RECEPTOR |
| US6309854B1 (en) | 1996-12-17 | 2001-10-30 | Smithkline Beecham Corporation | Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72 |
| US5935814A (en) | 1997-04-30 | 1999-08-10 | Smithkline Beecham Corporation | Polynucleotides encoding HFGAN72Y receptor |
| US6020157A (en) | 1997-04-30 | 2000-02-01 | Smithkline Beecham Corporation | Polynucleotides encoding HFGAN72X receptor |
| US6166193A (en) | 1997-07-25 | 2000-12-26 | Board Of Regents, University Of Texas System | Polynucleotides encoding MY1 receptor |
| AU2011304285B2 (en) | 2010-09-22 | 2015-01-29 | Eisai R&D Management Co., Ltd. | Cyclopropane compound |
| BR112014019909B1 (pt) | 2012-02-17 | 2020-01-28 | Eisai R&D Man Co Ltd | processo para produção de compostos úteis como antagonistas do receptor de orexina-2 |
| ES2843952T3 (es) | 2014-10-23 | 2021-07-21 | Eisai R&D Man Co Ltd | Composiciones para tratar el insomnio |
| CA3051830A1 (en) * | 2017-01-27 | 2018-08-02 | Neurocrine Bioscienes, Inc. | Methods for the administration of certain vmat2 inhibitors |
-
2020
- 2020-12-18 MX MX2022007304A patent/MX2022007304A/es unknown
- 2020-12-18 EP EP20842786.4A patent/EP4076463A1/en active Pending
- 2020-12-18 CA CA3165481A patent/CA3165481A1/en active Pending
- 2020-12-18 CN CN202080094379.0A patent/CN115003305A/zh active Pending
- 2020-12-18 BR BR112022012246A patent/BR112022012246A2/pt unknown
- 2020-12-18 US US17/757,672 patent/US20230051268A1/en active Pending
- 2020-12-18 JP JP2022537669A patent/JP2023508011A/ja active Pending
- 2020-12-18 AU AU2020408557A patent/AU2020408557A1/en active Pending
- 2020-12-18 TW TW109145085A patent/TW202137986A/zh unknown
- 2020-12-18 WO PCT/US2020/065891 patent/WO2021127359A1/en not_active Ceased
- 2020-12-18 KR KR1020227023903A patent/KR20220119065A/ko active Pending
-
2025
- 2025-08-06 JP JP2025131238A patent/JP2025160480A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN115003305A (zh) | 2022-09-02 |
| BR112022012246A2 (pt) | 2022-08-30 |
| JP2025160480A (ja) | 2025-10-22 |
| EP4076463A1 (en) | 2022-10-26 |
| TW202137986A (zh) | 2021-10-16 |
| JP2023508011A (ja) | 2023-02-28 |
| CA3165481A1 (en) | 2021-06-24 |
| WO2021127359A1 (en) | 2021-06-24 |
| KR20220119065A (ko) | 2022-08-26 |
| AU2020408557A1 (en) | 2022-08-11 |
| US20230051268A1 (en) | 2023-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY201603A (en) | Combination of dextromethorphan and bupropion for treating depression | |
| UY35624A (es) | Uso de dosis elevadas de pridopidina para tratar la enfermedad de huntington | |
| PH12019500025A1 (en) | Cancer treatment combinations | |
| PE20150161A1 (es) | Uso de laquinimod de dosis alta para el tratamiento de esclerosis multiple | |
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| ZA202000028B (en) | Use of vibegron to treat overactive bladder | |
| CR20230539A (es) | ANÁLOGOS DE BENZOAZEPINA COMO AGENTES INHIBIDORES DE LA TORISINA CINASA DE BRUTON (Divisional 2019-0517) | |
| PH12020551911A1 (en) | Use of riluzole oral disintigrating tablets for treating diseases | |
| MX2024007642A (es) | Uso de tabletas de desintegracion oral de riluzol para tratar enfermedades. | |
| ZA202204907B (en) | Orally disintegrating pharmaceutical compositions of apixaban | |
| AU2018282105A1 (en) | Dosing of vibegron for treatment of overactive bladder | |
| PH12019500516A1 (en) | Pharmaceutical composition comprising mineralocorticoid receptor antagonist and use thereof | |
| MX2015009546A (es) | Dosificacion aumentada de efavirenz para el tratamiento de cancer. | |
| MX2022007304A (es) | Uso de lemborexant para tratamiento del insomnio. | |
| RU2020108631A (ru) | Новая вспомогательная терапия для применения в способе лечения рака простаты | |
| RU2016103099A (ru) | Способ предотвращения и/или лечения хронической травматической энцефалопатии - i | |
| HRP20230693T1 (hr) | Uporaba inhibitora acetilkolinesteraze i idalopirdina za smanjenje padova kod pacijenata oboljelih od parkinsonove bolesti | |
| MX2021007324A (es) | Terapia oral con acido 6,8-bis-benciltio-octanoico. | |
| PL425832A1 (pl) | Genisteina oraz jej kompozycja do zastosowania w leczeniu choroby Alzheimera | |
| PH12019501607A1 (en) | Tapentadol nasal composition | |
| MX2022002038A (es) | Composicion farmaceutica para el tratamiento del insomnio. | |
| WO2016187595A3 (en) | Oral pharmaceutical composition of methylergonovine | |
| ZA202206042B (en) | Treating behavioral and psychological symptoms in dementia patients | |
| RU2018133603A (ru) | Пероральная дозированная форма двух изомеров кломифена и способ ее использования для лечения вторичного гипогонадизма и минимизации побочных эффектов лекарственного препарата у мужчин | |
| WO2016193456A3 (en) | Opioid receptor antagonist for use in treating patients with severe constipation |